Ryan Specialty (RYAN): insider & executive buying
Ryan Specialty · Financials · ref. ETF XLF · price $43.5
In short — 5 insiders bought Ryan Specialty over ~6 months (5 buys, total $4.6M, latest Jun 11, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are Ryan Specialty's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$43.5-23.2% over range
Aug 28, 25low $29.39 · high $58.38Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
54% recommend buying · 13 analysts
Latest insider buys on Ryan Specialty
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Jun 11, 26 | Kuczinski Anthony J | Dir | 3,000 | $105k |
| Jun 10, 26 | Rogers John W Jr | Dir | 7,500 | $264k |
| Jun 5, 26 | Ryan Patrick G | Exec COB, 10% | 120,000 | $3.9M |
| Jun 3, 26 | Hamilton Janice M | CFO | 6,300 | $200k |
| Jun 3, 26 | Katz Mark Stephen | EVP, GC | 3,215 | $100k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Ryan Specialty's executives bought shares recently?
5 Ryan Specialty insider(s) bought $4.6M over ~6 months (latest Jun 11, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for RYAN?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Ryan Specialty? The JPI assistant answers using our backtest data.